Immunochernotherapy in indolent non-Hodgkin's lymphoma

被引：24

作者：

Czuczman, MS ^{[1
]}

机构：

[1] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 02期

关键词：

D O I：

10.1053/sonc.2002.32748

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：11 / 17

页数：7

共 49 条

[1] COHERENT VIEW OF NON-HODGKINS-LYMPHOMA
AISENBERG, AC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) : 2656 - 2675
[2] Alas S, 2000, ANTICANCER RES, V20, P2961
[3] [Anonymous], CLEVELAND CLIN J MED
[4] HUMAN-B LYMPHOCYTES - PHENOTYPE, PROLIFERATION, AND DIFFERENTIATION
BANCHEREAU, J
ROUSSET, F
[J]. ADVANCES IN IMMUNOLOGY, 1992, 52 : 125 - 262
[5] BERTRAM J, 1997, EJC SUPPL, V33, P55
[6] TRANSFECTION OF THE CD20 CELL-SURFACE MOLECULE INTO ECTOPIC CELL-TYPES GENERATES A CA2+ CONDUCTANCE FOUND CONSTITUTIVELY IN B-LYMPHOCYTES
BUBIEN, JK
ZHOU, LJ
BELL, PD
FRIZZELL, RA
TEDDER, TF
[J]. JOURNAL OF CELL BIOLOGY, 1993, 121 (05) : 1121 - 1132
[7] The rise in incidence of lymphomas in Europe 1985-1992
Cartwright, R
Brincker, H
Carli, PM
Clayden, D
Coebergh, JW
Jack, A
McNally, R
Morgan, G
de Sanjose, S
Tumino, R
Vornanen, M
[J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (04) : 627 - 633
[8] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Coiffier, B
Lepage, E
Brière, J
Herbrecht, R
Tilly, H
Bouabdallah, R
Morel, P
Van den Neste, E
Salles, G
Gaulard, P
Reyes, F
Gisselbrecht, C
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) : 235 - 242
[9] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
Czuczman, MS
Grillo-López, AJ
White, CA
Saleh, M
Gordon, L
LoBuglio, AF
Jonas, C
Klippenstein, D
Dallaire, B
Varns, C
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 268 - 276
[10] Czuczman MS, 2000, BLOOD, V96, p729A

← 1 2 3 4 5 →